合計 50 件の最近のインサイダー取引記録が記録されています Pliant Therapeutics, Inc. (PLRX), 内訳は 32 件の買い および 16 件の売り. インサイダー買い総額は $14.05M インサイダー売り総額は $2.58M.
最近活動のある主要インサイダーには Coulie Bernard, Cummings Keith Lamont, Cheung Lily. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — PLRX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-01-22 |
Coulie Bernard |
President and CEO |
RSU 付与（制限付株式） |
1,230,000 |
$1.30 |
$1.6M |
1,230,000 |
| 2026-01-22 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU 付与（制限付株式） |
400,000 |
$1.30 |
$520K |
400,000 |
| 2026-01-22 |
Cheung Lily |
Chief Human Resource Officer |
RSU 付与（制限付株式） |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-22 |
Kuo Minnie |
Chief Operating Officer |
RSU 付与（制限付株式） |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-20 |
Coulie Bernard |
President and CEO |
情報に基づく売り |
89,375 |
$1.28 |
$114.4K |
505,601 |
| 2026-01-20 |
Cummings Keith Lamont |
Chief Financial Officer |
情報に基づく売り |
24,002 |
$1.28 |
$30.72K |
297,214 |
| 2026-01-20 |
Cheung Lily |
Chief Human Resource Officer |
情報に基づく売り |
7,534 |
$1.28 |
$9.64K |
44,847 |
| 2026-01-20 |
Kuo Minnie |
Chief Operating Officer |
情報に基づく売り |
6,917 |
$1.28 |
$8.85K |
37,806 |
| 2025-12-10 |
Kuo Minnie |
Chief Operating Officer |
不明 |
55,200 |
$11.14 |
$614.93K |
- |
| 2025-06-05 |
Pyott David E I |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Crowell Gayle A |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Huh Hoyoung |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Mccourt Thomas A |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Bruhn Suzanne Louise |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Curnutte John T |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Cline Darren S |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Krognes Steve E. |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Knobil Katharine |
Director |
RSU 付与（制限付株式） |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-01-23 |
Lefebvre Eric |
Chief Medical Officer |
RSU 付与（制限付株式） |
91,300 |
$11.14 |
$1.02M |
91,300 |
| 2025-01-23 |
Hull Hans |
Chief Business Officer |
RSU 付与（制限付株式） |
80,300 |
$11.14 |
$894.54K |
80,300 |
| 2025-01-23 |
Coulie Bernard |
President and CEO |
RSU 付与（制限付株式） |
325,000 |
$11.14 |
$3.62M |
325,000 |
| 2025-01-23 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU 付与（制限付株式） |
113,300 |
$11.14 |
$1.26M |
113,300 |
| 2025-01-23 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
RSU 付与（制限付株式） |
70,000 |
$11.14 |
$779.8K |
70,000 |
| 2025-01-23 |
Cheung Lily |
Chief Human Resource Officer |
RSU 付与（制限付株式） |
25,875 |
- |
- |
50,425 |
| 2025-01-22 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
情報に基づく売り |
10,230 |
$10.99 |
$112.46K |
70,544 |
| 2025-01-17 |
Lefebvre Eric |
Chief Medical Officer |
情報に基づく売り |
18,478 |
$11.20 |
$206.97K |
194,574 |
| 2025-01-17 |
Hull Hans |
Chief Business Officer |
情報に基づく売り |
15,936 |
$11.20 |
$178.5K |
211,558 |
| 2025-01-17 |
Coulie Bernard |
President and CEO |
情報に基づく売り |
52,419 |
$11.20 |
$587.15K |
430,517 |
| 2025-01-17 |
Cummings Keith Lamont |
Chief Financial Officer |
情報に基づく売り |
20,148 |
$11.20 |
$225.68K |
262,608 |
| 2025-01-17 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
情報に基づく売り |
13,270 |
$11.20 |
$148.64K |
80,774 |
| 2025-01-17 |
Cheung Lily |
Chief Human Resource Officer |
情報に基づく売り |
3,740 |
$11.20 |
$41.89K |
24,550 |
| 2024-07-10 |
Lefebvre Eric |
Chief Medical Officer |
情報に基づく売り |
12,319 |
$11.56 |
$142.41K |
213,052 |
| 2024-07-10 |
Hull Hans |
Chief Business Officer |
情報に基づく売り |
9,900 |
$11.56 |
$114.44K |
227,494 |
| 2024-07-10 |
Coulie Bernard |
President and CEO |
情報に基づく売り |
38,710 |
$11.56 |
$447.49K |
482,936 |
| 2024-07-10 |
Cummings Keith Lamont |
Chief Financial Officer |
情報に基づく売り |
10,911 |
$11.56 |
$126.13K |
282,115 |
| 2024-07-10 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
情報に基づく売り |
7,656 |
$11.56 |
$88.5K |
94,044 |
| 2024-07-09 |
Lefebvre Eric |
Chief Medical Officer |
RSU 付与（制限付株式） |
24,063 |
- |
- |
225,371 |
| 2024-07-09 |
Hull Hans |
Chief Business Officer |
RSU 付与（制限付株式） |
19,337 |
- |
- |
237,394 |
| 2024-07-09 |
Coulie Bernard |
President and CEO |
RSU 付与（制限付株式） |
75,625 |
- |
- |
521,646 |
| 2024-07-09 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU 付与（制限付株式） |
21,313 |
- |
- |
293,026 |
| 2024-07-09 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
RSU 付与（制限付株式） |
14,954 |
- |
- |
101,700 |
| 2024-06-13 |
Pyott David E I |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Crowell Gayle A |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Huh Hoyoung |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Mccourt Thomas A |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Bruhn Suzanne Louise |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Curnutte John T |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Cline Darren S |
Director |
RSU 付与（制限付株式） |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Krognes Steve E. |
Director |
不明 |
- |
- |
- |
- |
| 2024-06-13 |
Krognes Steve E. |
Director |
RSU 付与（制限付株式） |
53,528 |
$13.06 |
$699.08K |
53,528 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
